Flexeril Indications Self-Diagnosis Seen As Significant Hurdle By Committee
This article was originally published in The Tan Sheet
Executive Summary
The ability of patients to accurately detect when they would need to use Flexeril 5 mg (cyclobenzaprine) is a significant hurdle the drug would need to overcome in a switch from the Rx to the OTC environment, according to discussions by FDA's Nonprescription Drugs and Arthritis Advisory Committees July 20.